Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback